January 2023 Banner

COVID19 UPDATES

FDA UPDATES

EUA UPDATES

Slide

Slide 1

Learn More

IEC

Featured Activity || On 16 December 2022, the Food and Drug Administration (FDA) conducted a Licensing Seminar held at the Bohol Tropics, Tagbilaran City, Bohol.

By Administrator 3 / December 28, 2022

On 16 December 2022, the Food and Drug Administration (FDA) conducted a Licensing Seminar held at the Bohol Tropics, Tagbilaran...

Featured Activity || 18th NBW (DOH – FDA Healthcare Forum on Biotechnology)

By Administrator 3 / December 1, 2022

On 21 – 25 November 2022, the annual celebration of the 18th National Biotechnology Week (NBW) pursuant to Proclamation No....

Featured Activity || 18th NBW (DOH – FDA Healthcare Forum on Biotechnology)

Featured Activity || Anti-Red Tape Authority (ARTA) “Streamlining and Digitalization of Government Processes in the Health Sector During and Beyond the Pandemic”

By Administrator 3 / November 24, 2022

The Food and Drug Administration (FDA) participated in the health forum conducted by the Anti-Red Tape Authority (ARTA) with the...

Featured Activity || Anti-Red Tape Authority (ARTA) “Streamlining and Digitalization of Government Processes in the Health Sector During and Beyond the Pandemic”

Featured Activity || Philippine Antimicrobial Awareness Week

By Administrator 3 / November 24, 2022

The Food and Drug Administration (FDA) participated in the Philippine Antimicrobial Awareness Week 2002 last Tuesday, November 22 at Seda...

Featured Activity || Philippine Antimicrobial Awareness Week

Featured Activity || The Food and Drug Administration (FDA) in Central Luzon, NBI NCR, and NBI Bulacan District Office seized counterfeit products worth P300 million in a recent raid on nine (9) establishments in Bulacan.

By Administrator 3 / November 2, 2022

The Food and Drug Administration (FDA) in Central Luzon, NBI NCR, and NBI Bulacan District Office seized counterfeit products worth...

Featured Activity || The Food and Drug Administration (FDA) in Central Luzon, NBI NCR, and NBI Bulacan District Office seized counterfeit products worth P300 million in a recent raid on nine (9) establishments in Bulacan.

Featured Activity || The Food and Drug Administration (FDA) participated in the Better Regulations Summit 2022 held by the Anti-Red Tape Authority (ARTA) last Friday, October 7 at the Philippine International Convention Center.

By Administrator 3 / October 12, 2022

The Food and Drug Administration (FDA) participated in the Better Regulations Summit 2022 held by the Anti-Red Tape Authority (ARTA)...

Featured Activity || The Food and Drug Administration (FDA) participated in the Better Regulations Summit 2022 held by the Anti-Red Tape Authority (ARTA) last Friday, October 7 at the Philippine International Convention Center.

Featured Activity || The Food and Drug Administration (FDA) participated in the three-day International Food Exhibition (IFEX) Philippines 2022 held last September 22 to 24 at the World Trade Center Metro Manila in Pasay City.

By Administrator 3 / October 3, 2022

The Food and Drug Administration (FDA) participated in the three-day International Food Exhibition (IFEX) Philippines 2022 held last September 22...

Featured Activity || The Food and Drug Administration (FDA) participated in the three-day International Food Exhibition (IFEX) Philippines 2022 held last September 22 to 24 at the World Trade Center Metro Manila in Pasay City.

Featured Activity || The Philippine Association of Pharmacists in Veterinary Industry (PAPVI) pays a courtesy visit to the Food and Drug Administration (FDA) Director General Dr. Samuel A. Zacate.

By Administrator 3 / September 23, 2022

The Philippine Association of Pharmacists in Veterinary Industry (PAPVI) pays a courtesy visit to the Food and Drug Administration...

Featured Activity || The Philippine Association of Pharmacists in Veterinary Industry (PAPVI) pays a courtesy visit to the Food and Drug Administration (FDA) Director General Dr. Samuel A. Zacate.

Featured Activity || The Food and Drug Administration (FDA) participated in the three-day World Trade Organization-Technical Barriers to Trade (WTO-TBT) National Workshop on 13-15 September.

By Administrator 3 / September 22, 2022

The Food and Drug Administration (FDA) participated in the three-day World Trade Organization-Technical Barriers to Trade (WTO-TBT) National Workshop on...

Featured Activity || The Food and Drug Administration (FDA) participated in the three-day World Trade Organization-Technical Barriers to Trade (WTO-TBT) National Workshop on 13-15 September.

Featured Event

Play

Featured Video

Play

Our Services

For Products and Establishments registration at FDA

COVID19-related Updates

(Click Logo below for Updates)

Latest Advisories

FDA Advisory No.2022-1812-A || Lifting the Advisory on the Notified Cosmetic Product “BRILLIANT SKIN ESSENTIALS SUNSCREEN GEL-CREAM HAND AND BODY CREAM SPF 50” under FDA Advisory No. 2022-1812 “Public Health Warning Against the Purchase and Use of Unnotified Cosmetic Product “BRILLIANT SKIN ESSENTIALS SUNSCREEN GEL-CREAM HAND AND BODY CREAM SPF 50” dated 26 October 2022.

By Administrator 2 / February 3, 2023

The Food and Drug Administration (FDA) informs the public that the cosmetic product Brilliant Skin Essentials Sunscreen Gel-Cream Hand and...

FDA Advisory No.2022-2072-A || Lifting the Advisory on the Notified Cosmetic Product “THE FACE SHOP REAL NATURE SHEA BUTTER” under FDA Advisory No. 2022-2072 “Public Health Warning Against the Purchase and Use of Unnotified Cosmetic Product ” THE FACE SHOP REAL NATURE SHEA BUTTER ” dated 16 December 2022.

By Administrator 2 / February 3, 2023

The Food and Drug Administration (FDA) informs the public that the cosmetic product The Face Shop Real Nature Shea Butter...

FDA Advisory No.2023-0165 || INTEGRATION OF LANDBANK LINK.BIZPORTAL TO THE FDA ESERVICES PORTAL

By Administrator 3 / February 2, 2023

The Food and Drug Administration (FDA), in its commitment to provide effective and efficient public health service delivery, has integrated...

FDA Advisory No.2022-1220-A || Lifting the Advisory on the Notified Toys and Childcare Article “LI’L HANDS ARTS AND CRAFTS MODELLING CLAY” under FDA Advisory No. 2022-1220 “Public Health Warning Against the Purchase and Use of the Unauthorized Toy and Childcare Article “LI’L HANDS ARTS AND CRAFTS MODELLING CLAY ” dated 27 June 2022.

By Administrator 3 / February 2, 2023

The Food and Drug Administration (FDA) informs the public that the toy and childcare article Li’l Hands Arts and Crafts...

FDA Advisory No.2023-0139 || Public Health Warning Against the Purchase and Use of the following Adulterated Cosmetic Products as Reported in the ASEAN Post-Marketing Alert System (PMAS):

By Administrator 3 / February 2, 2023

The Food and Drug Administration (FDA) warns the public from purchasing and using the following adulterated cosmetic products which tested...

FDA Advisory No.2023-0163-A || Babala sa Publiko tungkol sa Paggamit ng Beripikadong Pekeng Gamot na “Xeomin 100 units powder for solution for injection Clostridium Botulinum neurotoxin type A (150kD). free from complexing proteins”

By Administrator 2 / January 31, 2023

Pinapayuhan ng Food and Drug Administration (FDA) ang publiko laban sa pagbili at paggamit ng beripikadong pekeng gamot: Xeomin 100...

FDA Advisory No.2023-0164-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:

By Administrator 3 / January 31, 2023

Pinapayuhan ng Food and Drug Administration (FDA) ang publiko laban sa pagbili at paggamit ng mga sumusunod na hindi rehistradong...

FDA Advisory No.2023-0163 || Public Health Warning Against the Purchase and Use of the Counterfeit Drug Product “Xeomin 100 units powder for solution for injection Clostridium Botulinum neurotoxin type A (150kD). free from complexing proteins”

By Administrator 2 / January 31, 2023

The Food and Drug Administration (FDA) advises the public against the purchase and use of the counterfeit version of the...

FDA Advisory No.2023-0162-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:

By Administrator 2 / January 31, 2023

Pinapayuhan ng Food and Drug Administration (FDA) ang publiko laban sa pagbili at paggamit ng mga sumusunod na hindi rehistradong...

FDA Advisory No.2023-0164 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:

By Administrator 3 / January 31, 2023

The Food and Drug Administration (FDA) advises the public against the purchase and use of the following unregistered drug products:...

Announcement || Implementation of the Food and Drug Administration (FDA) Eservices Portal System for the License to Operate (LTO) of Pest Control Operator (PCO) Establishments

The FDA hereby announces that the License to Operate (LTO) for Pest Control Operator (PCO) Establishments through the eServices Portal ...
Read More

February 1, 2023

FDA ORDER No.2022-1365-A || Lifting the Temporary Ban of Entry of Cured Pork Meat Products from Italy

In the interest of consistency and coherent efforts in preventing the entry of African Swine Fever Virus in the country, ...
Read More

January 26, 2023

GOOD DISTRIBUTION AND STORAGE PRACTICE FOR DRUG PRODUCTS (DRUGSTORES AND HOSPITAL PHARMACIES) GDSP-DS AND HP

The program will provide an introduction to Good Distribution and Storage Practice (GDSP) for Drugstores and Hospital Pharmacies and its ...
Read More

January 25, 2023

FDA on the News

FDA on the News || What’s inside the Food and Drug Administration? Watch and know more about FDA under its new leadership, Director General Samuel A. Zacate

By Administrator 3 / November 26, 2022

Alam niyo ba na halos lahat ng kinokonsumo ng tao ay kailangan dumaan sa masusing pagsusuri ng Food and Drug...

FDA on the News || Giyera kontra counterfeit items, idineklara ng FDA Chief

By Administrator 3 / November 19, 2022

Nagdeklara ang Food and Drug Administration ng war agaisnt counterfeit medicines. Ang pahayag ng FDA kasabay ng pagdiriwang ng National...

FDA on the News || Pinangungunahan ng Food and Drug Administration (FDA) ang pagdiriwang ng ‘National Consciousness Week Against Counterfeit Medicine.’

By Administrator 3 / November 18, 2022

TINGNAN | Pinangungunahan ng Food and Drug Administration (FDA) ang pagdiriwang ng 'National Consciousness Week Against Counterfeit Medicine.' Kasalukuyang ginaganap...

FDA on the News || Food and Drug Administration (FDA) Harmonies graced the program In the Heart of Business by DWIZ 882 last Friday, November 11.

By Administrator 3 / November 15, 2022

They performed their renditions of True Colors by Cyndi Lauper and "Pekeng Gamot," which was composed by Mr. Jonathan Sta....

Meet FDA Chief Eric Domingo, on COVID-19 response

By Administrator / January 17, 2021

READ HERE: https://news.abs-cbn.com/ancx/culture/spotlight/01/17/21/which-covid-19-vaccine-does-the-filipino-deserve-its-up-to-this-guy-to-decide?fbclid=IwAR1k3zjxBwgS-9xpkCVaWM4bCbpI5TMvLWON2FCrLSOkzlqQ6Ws42AxZKXI

PH FDA QUALIFIES AS 5th ASEAN INSPECTION SERVICE

By Administrator / May 15, 2019

PH FDA QUALIFIES AS 5th ASEAN LISTED INSPECTION SERVICE - The Philippine Food and Drug Administration (FDA) has successfully qualified...

FDA Chief Orders Clean-Up Of Backlog

By Administrator / July 15, 2018

The Food and Drug Administration (FDA) is set to take drastic moves to address the backlog in the processing of...

FDA chief bats for early cancer detection

By Administrator / May 27, 2018

Food and Drug Administration (FDA) Director-General Nela Charade G. Puno last week called on women to have regular breast examinations,...

Press Release || The Food and Drug Administration (FDA), in partnership with the Local Government Units (LGUs), launches the Bigyang-halaga, Bangon MSMEs (Micro, Small, and Medium Enterprises) Program.

By Administrator 3 / January 13, 2023

The Food and Drug Administration (FDA), in partnership with the Local Government Units (LGUs), launches the Bigyang-halaga, Bangon MSMEs (Micro,...

FDA Press Statement || Updates on the Voluntary Recall of Sangobion Kids Syrup

By Administrator 3 / January 13, 2023

The Food and Drug Administration (FDA) issued FDA Advisory No. 2022-1968 on the voluntary recall of Iron + Vitamin B...

FDA STATEMENT || On Diethylene glycol and Ethylene glycol – contaminated Cough and Cold Syrup Manufactured by Maiden Pharmaceuticals, Ltd.

By Administrator 3 / October 28, 2022

All pharmaceutical products, especially cough and cold syrups, that use glycerine as solvent, diluent, and thickening agent, are mandatorily required...

Press Statement || The Food and Drug Administration (FDA) Launches Taskforce Edward Which Aims to Make Safe and Effective COVID-19 Vaccines More Accessible to All Filipinos

By Administrator 3 / August 16, 2022

Food and Drug Administration (FDA) Director General Dr. Samuel Zacate launches Taskforce Edward which has the primary objective to make...

Press Statement || The Food and Drug Administration (FDA) joins the Department of Health (DOH) in requesting the Presidential veto of Senate Bill No. 2239 and House Bill No. 9007, or the Vape Bill. The FDA strongly echoes the sentiments of the DOH that the Vape Bill is not a health bill.

By Administrator 2 / July 21, 2022

The Food and Drug Administration (FDA) joins the Department of Health (DOH) in requesting the Presidential veto of Senate Bill...

FDA STATEMENT || ACTIONS RELATIVE TO THE EU-RASFF ALERT ON LUCKY ME! INSTANT NOODLE PRODUCTS MANUFACTURED IN THAILAND

By Administrator 2 / July 11, 2022

The FDA received a copy of the European Union Rapid Alert System for Food and Feed (EU-RASFF) that Lucky Me!...

Press Release || FDA lauds SC decision upholding the agency’s regulatory authority over tobacco products 23 June 2022

By Administrator 2 / June 24, 2022

The Food and Drug Administration (FDA) lauds the Supreme Court decision upholding the agency’s jurisdiction over tobacco products reaffirming the...

Press Statement || FDA Philippines Grants Emergency Use Authorization of CoronaVac (Sinovac) for Pediatric Group

By Administrator 2 / March 15, 2022

On 11 March 2022, the Food and Drug Administration (FDA) granted the Emergency Use Authorization (EUA) of CoronaVac Vaccine, manufactured...

Press Release || FDA APPROVES SELF-ADMINISTERED COVID-19 ANTIGEN TEST KITS

By Administrator 2 / January 25, 2022

The Food and Drug Administration (FDA) has approved two (2) self-administered COVID-19 antigen test kits in compliance with the application...

OFFICIAL STATEMENT OF THE FOOD AND DRUG ADMINISTRATION (FDA) ON THE ALLEGED IRREGULARITIES DURING INSPECTION AT MARKET REACH INTERNATIONAL RESOURCES, CORP.

By Administrator 2 / June 8, 2021

08 June 2021 The FDA will fully cooperate with the NBI on the alleged irregularities during inspection at Market Reach...

Draft for Comments || Guidelines on Food and Drug Administration’s Regulatory Responses During Declared National or State of Public Health Emergencies

By Administrator 2 / January 31, 2023

All comments may be sent at [email protected] The deadline for submission of comments is on 15 February 2023. I. RATIONALE In upholding...

Draft for Comments || Guidelines on Food and Drug Administration’s Regulatory Responses During Declared National or State of Public Health Emergencies

Draft for Comments || Updated Guidelines for Availing Compassionate Special Permit for the Restricted Use of Unregistered or Unauthorized Drug Products including Vaccines and Medical Devices

By Administrator 2 / January 26, 2023

All comments may be sent at [email protected] The deadline for submission of comments is on 09 February 2023. I. BACKGROUND...

Draft for Comments || Updated Guidelines for Availing Compassionate Special Permit for the Restricted Use of Unregistered or Unauthorized Drug Products including Vaccines and Medical Devices

Draft for Comments || Addendum to Administrative Order No. 50 s. 2001 entitled “Revised 2001 Schedule of fees and Charges for the Corresponding Services Rendered by the Bureau of Food and Drugs.”

By Administrator 3 / January 26, 2023

All comments may be sent at [email protected] The deadline for submission of comments is on 09 February 2023. I. RATIONALE On...

Draft for Comments || Addendum to Administrative Order No. 50 s. 2001 entitled “Revised 2001 Schedule of fees and Charges for the Corresponding Services Rendered by the Bureau of Food and Drugs.”

Draft for Comments || Revised Guidelines on Food Additives and Processing Aids, Repealing Administrative Order 88-A s. 1984

By Administrator 2 / January 19, 2023

You may submit your comments in MSWord format to [email protected] The deadline for submission of comments is on 03 February 2023. Draft for...

Draft for Comments || Revised Guidelines on Food Additives and Processing Aids, Repealing Administrative Order 88-A s. 1984

Draft for Comments || Guidelines on the Adoption of 2015 Philippine Dietary Reference Intakes (PDRI) for Declaration of Nutrition Information on the Labels Repealing Bureau Circular No. 16 s. 2005 entitled “Adopting the 2002 Recommended Energy and Nutrient Intakes as the New Dietary Standard”

By Administrator 2 / January 18, 2023

You may submit your comments in MSWord format to [email protected] The deadline for submission of comments is on 02 February 2023. Draft for...

Draft for Comments || Guidelines on the Adoption of 2015 Philippine Dietary Reference Intakes (PDRI) for Declaration of Nutrition Information on the Labels Repealing Bureau Circular No. 16 s. 2005 entitled “Adopting the 2002 Recommended Energy and Nutrient Intakes as the New Dietary Standard”

Draft for Comments || Guidelines Prescribing the Principle of Reliance for Regulatory Decisions of the Food and Drug Administration

By Administrator 2 / November 25, 2022

All comments may be sent at [email protected] with the following Subject format: a. Comments_AO on Reliance for Regulatory Decision

Draft for Comments || Guidelines Prescribing the Principle of Reliance for Regulatory Decisions of the Food and Drug Administration

Draft for Comments || Guidelines on Food and Drug Administration’s Regulatory Responses During Declared National Public Health Emergencies

By Administrator 2 / November 25, 2022

All comments may be sent at [email protected] with the following Subject format: a. Comments_AO on National Public Health Emergencies

Draft for Comments || Guidelines on Food and Drug Administration’s Regulatory Responses During Declared National Public Health Emergencies

Draft for Comments || Guidelines on Ethylene Oxide Residue Level in Raw Materials and Processed Prepackaged Food

By Administrator 3 / November 22, 2022

You may submit your comments in MSWord format to [email protected] Cc [email protected] on or before 08 December 2022 using the...

Draft for Comments || Guidelines on Ethylene Oxide Residue Level in Raw Materials and Processed Prepackaged Food

Draft for Comments || Guidelines on the Conduct of Regulatory Inspections for Radiation Facilities

By Administrator 3 / November 8, 2022

All comments and recommendations shall be sent to [email protected] I. BACKGROUND The Department of Health (DOH), through the issuance of...

Draft for Comments || Guidelines on the Conduct of Regulatory Inspections for Radiation Facilities

Draft for Comments || Amendment to Administrative Order No. 2020-0017 entitled, “Revised Guidelines on the Unified Licensing Requirements and Procedures of the Food and Drug Administration Repealing Administrative Order No. 2016-0003”

By Administrator 3 / October 3, 2022

All comments may be sent at [email protected] The deadline for submission of comments is on 14 October 2022. I. RATIONALE...

Draft for Comments || Amendment to Administrative Order No. 2020-0017 entitled, “Revised Guidelines on the Unified Licensing Requirements and Procedures of the Food and Drug Administration Repealing Administrative Order No. 2016-0003”

Bids and Awards

NP-SVP(A)-2023-0003-AFS || Procurement of the Construction Materials for the Renovation / Rehabilitation of FDA Annex Building Basement for Storage of Unserviceable/Condemned Office Equipment/Records file for Safekeeping

By Administrator 2 / January 26, 2023

Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Procurement of the Construction Materials for the Renovation / Rehabilitation of FDA Annex Building...

NP-SVP(A)-2023-0003-AFS || Procurement of the Construction Materials for the Renovation / Rehabilitation of FDA Annex Building Basement for Storage of Unserviceable/Condemned Office Equipment/Records file for Safekeeping

NP-SVP(A)-2022-0257-SLC || Procurement of Smart TV and Stand (Mobile)

By Administrator 2 / December 23, 2022

Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Procurement of Smart TV and Stand (Mobile)

NP-SVP(A)-2022-0257-SLC || Procurement of Smart TV and Stand (Mobile)

NP-SVP(A)-2022-0258-ICTMD || Procurement for the Repair / Retermination and Testing of FDA Fiber Optic Cable Located at CDRR

By Administrator 2 / December 22, 2022

Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Procurement for the Repair / Retermination and Testing of FDA Fiber Optic Cable Located...

NP-SVP(A)-2022-0258-ICTMD || Procurement for the Repair / Retermination and Testing of FDA Fiber Optic Cable Located at CDRR

NP-SVP(A)-2022-0256-AFS || Procurement of Memorabilia / Souvenir Items as Loyalty Incentives

By Administrator 2 / December 21, 2022

Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Procurement of Memorabilia / Souvenir Items as Loyalty Incentives Technical Specification

ITB No. 2022-0250-FROO-EPA || Procurement of One (1) Year Security Services for FDA Regional Field Offices and Warehouses, Cebu Testing and Quality Assurance Laboratory (CTQAL), and Davao Testing Quality Assurance Laboratory (DTQAL)

By Administrator 3 / December 20, 2022

Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Procurement of One (1) Year Security Services for FDA Regional Field Offices and Warehouses,...

ITB No. 2022-0250-FROO-EPA || Procurement of One (1) Year Security Services for FDA Regional Field Offices and Warehouses, Cebu Testing and Quality Assurance Laboratory (CTQAL), and Davao Testing Quality Assurance Laboratory (DTQAL)

NP-SVP(A)-2022-0255-RFO-NCR || Procurement of Tires for Toyota Innova (SKW-586) and Toyota Grandia (SKW-291)

By Administrator 2 / December 19, 2022

Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Procurement of Tires for Toyota Innova (SKW-586) and Toyota Grandia (SKW-291) ...

NP-SVP(A)-2022-0255-RFO-NCR || Procurement of Tires for Toyota Innova (SKW-586) and Toyota Grandia (SKW-291)

NP-SHPG(A)-2022-0251-ICTMD || Procurement for the ICT Equipment

By Administrator 3 / December 19, 2022

Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Procurement for the ICT Equipment

NP-SHPG(A)-2022-0251-ICTMD || Procurement for the ICT Equipment

NP-SVP(A)-2022-0242-ATQAL || Procurement for the Various Souvenir items for the Celebration of the 2022 National Counterfeit Week Against Counterfeit Medicines

By Administrator 3 / December 13, 2022

Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Procurement for the Various Souvenir items for the Celebration of the 2022 National Counterfeit...

NP-SVP(A)-2022-0242-ATQAL || Procurement for the Various Souvenir items for the Celebration of the 2022 National Counterfeit Week Against Counterfeit Medicines

NP-SVP(A)-2022-0237-AFS || Procurement of Memorabilia/ Souvenir Items as Loyalty Incentives

By Administrator 2 / December 13, 2022

Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Procurement of Memorabilia/ Souvenir Items as Loyalty Incentives Technical Specification

NP-SVP(A)-2022-0241-AFS || Procurement for the Construction Materials for the Renovation/Rehabilitation of FDA Annex Building Basement for Storage of Unserviceable/Condemed Office Equipment/Records file for Safekeeping

By Administrator 3 / December 12, 2022

Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Procurement for the Construction Materials for the Renovation/Rehabilitation of FDA Annex Building Basement for...

Featured Activity

Featured Event

Featured Video

Our Services

Verification Portal

eServices Portal

ePortal System

ePortal v.2 System

RRDportal

COVID19-related Updates

Latest Advisories

Announcement

FDA on the News

Press Statements

Draft for Comments

Bids and Awards

Latest Issuances

Quick Menus

Recent Posts

Quick Links

Contact Information

Address:

Mobile:

Email: [email protected]